Sign in

CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
520845822
Phone
352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 4 Other acquisition Director acquired 866 shares (other)
  2. 4 Other acquisition Director acquired 866 shares (other)
  3. SC 13D Stake Beneficial Ownership Report
  4. 8-K Event Executive or director change
  5. 4 Open-market buy Exec. Vice Chairman/CEO/Pres. bought 2,632 shares at $4.37 ($11,502)
  6. 4/A Open-market buy Exec. Vice Chairman/CEO/Pres. bought 29,404 shares at $4.03 ($118,498)
  7. 4 Open-market buy Chief Science/Medical Officer bought 2,481 shares at $4.03 ($9,998)
  8. 4 Open-market buy Dir Govt Relations/Sectry bought 8,695 shares at $4.03 ($35,041)
  9. 4 Open-market buy Director bought 9,677 shares at $4.03 ($38,998)
  10. 4 Open-market buy Sr. VP of Operations bought 5,211 shares at $4.03 ($21,000)
  11. 4 Open-market buy Director bought 9,677 shares at $4.03 ($38,998)
  12. 4 Open-market buy Exec. Vice Chairman/CEO/Pres. bought 29,404 shares at $4.03 ($118,498)
  13. SC 13D/A Stake Beneficial Ownership Report
  14. 4 Other acquisition Director acquired 711 shares (other)
  15. 4 Other acquisition Director acquired 711 shares (other)
  16. 4 Conversion Director acquired 340,000 shares (conversion)
  17. 4 Conversion Director acquired 340,000 shares (conversion)
  18. 4 Conversion Sr. VP of Operations acquired 85,000 shares (conversion)
  19. 4 Conversion Dir Govt Relations/Sectry acquired 153,000 shares (conversion)
  20. 4 Conversion Chief Science/Medical Officer acquired 85,000 shares (conversion)

Page 29 of 82 · 1,637 filings